Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
7.99
-0.08 (-0.99%)
Aug 21, 2025, 4:00 PM EDT
Obio Technology (Shanghai) Corp. Company Description
Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China.
The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research.
It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
The company was founded in 2013 and is headquartered in Shanghai, China.
Obio Technology (Shanghai) Corp., Ltd.
Country | China |
Founded | 2013 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 692 |
CEO | Oudong Pan |
Contact Details
Address: Building 19 Shanghai, 201321 China | |
Phone | 86 21 5858 5887 |
Website | obiosh.com |
Stock Details
Ticker Symbol | 688238 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
SIC Code | 8731 |
Key Executives
Name | Position |
---|---|
Oudong Pan | Founder, Chairman of the Board and GM |
Luyuan Xu | Deputy GM, Chief Financial Officer, Accounting Supervisor and Board Secretary |
Junyi Pan | Investment Director, GM of Regenerative Medicine Division and Director |
Fujie Wang | Vice President of Supply Chain and Information Technology and Director |
Shan Yin | Deputy GM and Director |
Qingmei Xia | Deputy General Manager |
Qinbin Wu | Deputy General Manager |
Xinglin Yang | R and D Director |
Jiali Yang | Deputy Director of Research & Development |
Houliang Wei | Vice President of Process Development |